OR51Q1
gene geneOn this page
Summary
OR51Q1 (olfactory receptor family 51 subfamily Q member 1, HGNC:14851) is a protein-coding gene on chromosome 11p15.4, encoding Olfactory receptor 51Q1 (Q8NH59). Odorant receptor.
Olfactory receptors interact with odorant molecules in the nose, to initiate a neuronal response that triggers the perception of a smell. The olfactory receptor proteins are members of a large family of G-protein-coupled receptors (GPCR) arising from single coding-exon genes. Olfactory receptors share a 7-transmembrane domain structure with many neurotransmitter and hormone receptors and are responsible for the recognition and G protein-mediated transduction of odorant signals. The olfactory receptor gene family is the largest in the genome.
Source: NCBI Gene 390061 — RefSeq curated summary.
At a glance
- GWAS associations: 8
- Clinical variants (ClinVar): 3 total
- MANE Select transcript:
NM_001004757
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:14851 |
| Approved symbol | OR51Q1 |
| Name | olfactory receptor family 51 subfamily Q member 1 |
| Location | 11p15.4 |
| Locus type | gene with protein product |
| Status | Approved |
| Ensembl gene | ENSG00000167360 |
| Ensembl biotype | protein_coding |
| Entrez | 390061 |
Gene structure
Transcript identifiers
Ensembl transcripts: 1 — 1 protein_coding
ENST00000300778
RefSeq mRNA: 1 — MANE Select: NM_001004757
NM_001004757
CCDS: CCDS31381
Canonical transcript exons
ENST00000300778 — 1 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001276439 | 5422111 | 5423206 |
Expression profiles
Bgee: expression breadth tissue_specific, 2 present calls, max score 48.28.
Top tissues by expression
112 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| sural nerve | UBERON:0015488 | 48.28 | silver quality |
| colonic epithelium | UBERON:0000397 | 41.78 | gold quality |
| calcaneal tendon | UBERON:0003701 | 41.04 | gold quality |
| granulocyte | CL:0000094 | 40.09 | gold quality |
| bone marrow cell | CL:0002092 | 39.15 | gold quality |
| ventricular zone | UBERON:0003053 | 36.48 | gold quality |
| cortical plate | UBERON:0005343 | 36.47 | gold quality |
| tonsil | UBERON:0002372 | 35.61 | gold quality |
| ganglionic eminence | UBERON:0004023 | 35.49 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 34.90 | gold quality |
| mucosa of stomach | UBERON:0001199 | 33.59 | gold quality |
| bone marrow | UBERON:0002371 | 33.27 | gold quality |
| liver | UBERON:0002107 | 32.45 | gold quality |
| muscle tissue | UBERON:0002385 | 32.17 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 32.15 | gold quality |
| right hemisphere of cerebellum | UBERON:0014890 | 31.34 | gold quality |
| leukocyte | CL:0000738 | 30.21 | gold quality |
| stromal cell of endometrium | CL:0002255 | 29.87 | gold quality |
| monocyte | CL:0000576 | 29.73 | gold quality |
| gall bladder | UBERON:0002110 | 29.45 | silver quality |
| corpus callosum | UBERON:0002336 | 29.42 | gold quality |
| urinary bladder | UBERON:0001255 | 29.37 | gold quality |
| duodenum | UBERON:0002114 | 28.14 | gold quality |
| primary visual cortex | UBERON:0002436 | 27.73 | gold quality |
| lymph node | UBERON:0000029 | 27.57 | gold quality |
| placenta | UBERON:0001987 | 27.53 | gold quality |
| adrenal tissue | UBERON:0018303 | 27.51 | gold quality |
| blood | UBERON:0000178 | 27.14 | gold quality |
| superior frontal gyrus | UBERON:0002661 | 27.14 | gold quality |
| islet of Langerhans | UBERON:0000006 | 26.55 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 0.98 |
Regulation
Is transcription factor: no
Cross-species orthologs
5 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Or51q1c | ENSMUSG00000094063 |
| mus_musculus | Or51q1 | ENSMUSG00000094520 |
| rattus_norvegicus | Or51q1 | ENSRNOG00000077204 |
| rattus_norvegicus | Or51q1e | ENSRNOG00000086459 |
| rattus_norvegicus | Or51q1d | ENSRNOG00000088630 |
Paralogs (51): OR51E2 (ENSG00000167332), OR51B5 (ENSG00000167355), OR51I1 (ENSG00000167359), OR52A5 (ENSG00000171944), OR52W1 (ENSG00000175485), OR51B6 (ENSG00000176239), OR51V1 (ENSG00000176742), OR52E2 (ENSG00000176787), OR51L1 (ENSG00000176798), OR51G2 (ENSG00000176893), OR51A7 (ENSG00000176895), OR51T1 (ENSG00000176900), OR51S1 (ENSG00000176922), OR51F2 (ENSG00000176925), OR51E1 (ENSG00000180785), OR56B4 (ENSG00000180919), OR52E4 (ENSG00000180974), OR52N2 (ENSG00000180988), OR52N1 (ENSG00000181001), OR52N5 (ENSG00000181009), OR56B2 (ENSG00000181017), OR56B1 (ENSG00000181023), OR52N4 (ENSG00000181074), OR52P1 (ENSG00000181109), OR52D1 (ENSG00000181609), OR52H1 (ENSG00000181616), OR52K2 (ENSG00000181963), OR52A1 (ENSG00000182070), OR51B4 (ENSG00000183251), OR52E8 (ENSG00000183269), OR52L1 (ENSG00000183313), OR51M1 (ENSG00000184698), OR52B6 (ENSG00000187747), OR51I2 (ENSG00000187918), OR52K1 (ENSG00000196778), OR51D1 (ENSG00000197428), OR51C1 (ENSG00000197674), OR52M1 (ENSG00000197790), OR52E6 (ENSG00000205409), OR52J3 (ENSG00000205495)
Protein
Protein identifiers
Olfactory receptor 51Q1 — Q8NH59 (reviewed: Q8NH59)
All UniProt accessions (1): Q8NH59
UniProt curated annotations — full annotation on UniProt →
Function. Odorant receptor.
Subcellular location. Cell membrane.
Polymorphism. A stop codon at position Arg-236 in the gene coding for this protein is responsible for functional diversity thus producing a pseudogene.
Similarity. Belongs to the G-protein coupled receptor 1 family.
RefSeq proteins (1): NP_001004757* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR000276 | GPCR_Rhodpsn | Family |
| IPR000725 | Olfact_rcpt | Family |
| IPR017452 | GPCR_Rhodpsn_7TM | Domain |
| IPR050402 | OR51/52/56-like | Family |
Pfam: PF13853
UniProt features (25 total): topological domain 8, transmembrane region 7, sequence variant 6, chain 1, glycosylation site 1, disulfide bond 1, sequence conflict 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q8NH59-F1 | 85.83 | 0.49 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Disulfide bonds (1): 99–191
Glycosylation sites (1): 6
Function
Pathways and Gene Ontology
Reactome pathways
1 pathways
| ID | Pathway |
|---|---|
| R-HSA-9752946 | Expression and translocation of olfactory receptors |
MSigDB gene sets: 19 (showing top):
GOBP_CELLULAR_RESPONSE_TO_LIPID, GOBP_SENSORY_PERCEPTION_OF_CHEMICAL_STIMULUS, GOBP_RESPONSE_TO_LIPID, KEGG_OLFACTORY_TRANSDUCTION, GOBP_DETECTION_OF_STIMULUS, GOBP_SENSORY_PERCEPTION, GOMF_OLFACTORY_RECEPTOR_ACTIVITY, GOMF_TRANSMEMBRANE_SIGNALING_RECEPTOR_ACTIVITY, GOMF_G_PROTEIN_COUPLED_RECEPTOR_ACTIVITY, GOBP_SENSORY_PERCEPTION_OF_SMELL, GOBP_G_PROTEIN_COUPLED_RECEPTOR_SIGNALING_PATHWAY, GOBP_DETECTION_OF_STIMULUS_INVOLVED_IN_SENSORY_PERCEPTION, ZNF274_TARGET_GENES, REACTOME_OLFACTORY_SIGNALING_PATHWAY, REACTOME_SENSORY_PERCEPTION
GO Biological Process (6): cellular response to lipid (GO:0071396), system process (GO:0003008), signal transduction (GO:0007165), G protein-coupled receptor signaling pathway (GO:0007186), sensory perception of smell (GO:0007608), detection of chemical stimulus involved in sensory perception of smell (GO:0050911)
GO Molecular Function (3): G protein-coupled receptor activity (GO:0004930), olfactory receptor activity (GO:0004984), signaling receptor activity (GO:0038023)
GO Cellular Component (2): plasma membrane (GO:0005886), membrane (GO:0016020)
Reactome top-level categories
Rollup of top-1 pathways:
| Category | Pathways |
|---|---|
| Olfactory Signaling Pathway | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| transmembrane signaling receptor activity | 2 |
| response to lipid | 1 |
| cellular response to chemical stimulus | 1 |
| multicellular organismal process | 1 |
| cell communication | 1 |
| cellular process | 1 |
| signaling | 1 |
| regulation of cellular process | 1 |
| cellular response to stimulus | 1 |
| G protein-coupled receptor activity | 1 |
| signal transduction | 1 |
| sensory perception of chemical stimulus | 1 |
| sensory perception of smell | 1 |
| detection of chemical stimulus involved in sensory perception | 1 |
| G protein-coupled receptor signaling pathway | 1 |
| detection of chemical stimulus involved in sensory perception of smell | 1 |
| molecular transducer activity | 1 |
| membrane | 1 |
| cell periphery | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
160 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| OR51Q1 | MAGEB16 | A2A368 | 472 |
| OR51Q1 | ANKDD1B | A6NHY2 | 462 |
| OR51Q1 | PDE4DIP | Q5VU43 | 451 |
| OR51Q1 | ZNF142 | P52746 | 447 |
| OR51Q1 | FAM220A | Q7Z4H9 | 447 |
| OR51Q1 | MS4A14 | Q96JA4 | 444 |
| OR51Q1 | MOB3C | Q70IA8 | 438 |
| OR51Q1 | RPTN | Q6XPR3 | 434 |
| OR51Q1 | ZNF117 | Q03924 | 417 |
| OR51Q1 | DNHD1 | Q96M86 | 399 |
| OR51Q1 | FTCD | O95954 | 398 |
| OR51Q1 | KPRP | Q5T749 | 392 |
| OR51Q1 | PRM3 | Q9NNZ6 | 370 |
| OR51Q1 | ABCA2 | Q9BZC7 | 357 |
| OR51Q1 | GOLGA8R | I6L899 | 350 |
IntAct
0 interactions, top by confidence:
ESM2 similar proteins: A0A3B3IT45, A6NGY5, O88628, P0C646, Q6IFG1, Q8NGF0, Q8NGF1, Q8NGF3, Q8NGH6, Q8NGH7, Q8NGH9, Q8NGI0, Q8NGI2, Q8NGJ2, Q8NGJ3, Q8NGJ4, Q8NGJ5, Q8NGJ6, Q8NGJ7, Q8NGJ9, Q8NGK1, Q8NGK2, Q8NGK3, Q8NGK4, Q8NGK5, Q8NGK6, Q8NH53, Q8NH55, Q8NH56, Q8NH57, Q8NH59, Q8NH60, Q8NH61, Q8NH63, Q8NH64, Q8TCB6, Q8VBV9, Q96RD2, Q96RD3, Q9H255
Diamond homologs: A0A3B3IT45, A4D2G3, A6NF89, A6NGY5, A6NL08, A6NL26, A6NMU1, A6NND4, O88628, P0C629, P0C646, P0C7N1, P0C7T3, P23266, P23273, P23274, P30954, Q13606, Q60888, Q62007, Q6IF63, Q6IFG1, Q6W049, Q8NGA6, Q8NGF0, Q8NGF1, Q8NGF3, Q8NGG8, Q8NGH5, Q8NGH6, Q8NGH7, Q8NGH8, Q8NGH9, Q8NGI0, Q8NGI1, Q8NGI2, Q8NGI3, Q8NGI7, Q8NGJ2, Q8NGJ3
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
3 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 3 |
| Likely benign | 0 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
256 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 11:5422632:T:TA | donor_gain | 0.6900 |
| 11:5422633:A:AA | donor_gain | 0.6900 |
| 11:5422852:A:AG | donor_gain | 0.6400 |
| 11:5422382:T:G | donor_gain | 0.6200 |
| 11:5422751:AG:A | acceptor_gain | 0.5900 |
| 11:5422752:GG:G | acceptor_gain | 0.5900 |
| 11:5422556:C:G | donor_gain | 0.5800 |
| 11:5422621:G:GT | donor_gain | 0.5800 |
| 11:5422945:GCT:G | acceptor_gain | 0.5700 |
| 11:5422740:T:G | acceptor_gain | 0.5600 |
| 11:5422751:A:AG | acceptor_gain | 0.5500 |
| 11:5422752:G:GG | acceptor_gain | 0.5500 |
| 11:5422944:A:AG | acceptor_gain | 0.5400 |
| 11:5422945:G:GG | acceptor_gain | 0.5400 |
| 11:5422793:GCTG:G | donor_gain | 0.5300 |
| 11:5422748:ACCAG:A | acceptor_gain | 0.5000 |
| 11:5422752:GGAT:G | acceptor_gain | 0.5000 |
| 11:5422797:G:GG | donor_gain | 0.5000 |
| 11:5422329:C:T | donor_gain | 0.4900 |
| 11:5422380:C:T | donor_gain | 0.4900 |
| 11:5422465:TTCA:T | donor_gain | 0.4900 |
| 11:5422536:G:GT | donor_gain | 0.4900 |
| 11:5422555:GC:G | donor_gain | 0.4800 |
| 11:5422562:C:A | donor_gain | 0.4800 |
| 11:5422750:CA:C | acceptor_loss | 0.4700 |
| 11:5422752:G:GA | acceptor_loss | 0.4700 |
| 11:5422559:T:G | donor_gain | 0.4600 |
| 11:5422643:T:A | donor_gain | 0.4600 |
| 11:5422493:C:T | donor_gain | 0.4500 |
| 11:5422502:C:G | donor_gain | 0.4500 |
AlphaMissense
2075 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 11:5422708:T:C | F170L | 0.750 |
| 11:5422710:C:A | F170L | 0.750 |
| 11:5422710:C:G | F170L | 0.750 |
| 11:5422996:T:C | F266L | 0.692 |
| 11:5422998:T:A | F266L | 0.692 |
| 11:5422998:T:G | F266L | 0.692 |
| 11:5422240:T:C | F14L | 0.627 |
| 11:5422242:C:A | F14L | 0.627 |
| 11:5422242:C:G | F14L | 0.627 |
| 11:5422525:T:C | F109L | 0.594 |
| 11:5422527:C:A | F109L | 0.594 |
| 11:5422527:C:G | F109L | 0.594 |
| 11:5422465:T:C | F89L | 0.575 |
| 11:5422467:C:A | F89L | 0.575 |
| 11:5422467:C:G | F89L | 0.575 |
dbSNP variants (sampled 300 via entrez): RS1000628252 (11:5420117 A>G), RS1001417440 (11:5420346 A>T), RS1002046728 (11:5420860 A>G), RS1002246071 (11:5421098 A>G), RS1002906938 (11:5423243 T>A,G), RS1002959272 (11:5423496 A>G), RS1004037829 (11:5423207 G>A,C), RS1005437881 (11:5421395 A>G), RS1006473131 (11:5422447 G>A,C), RS1006990196 (11:5421457 C>T), RS1007435795 (11:5420443 T>C), RS1008992210 (11:5423697 A>C,G), RS1009107625 (11:5421527 C>T), RS1009397816 (11:5420622 T>C), RS1009736508 (11:5420797 G>T)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
8 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST010725_20 | Malaria | 4.000000e-69 |
| GCST010725_33 | Malaria | 2.000000e-67 |
| GCST010725_51 | Malaria | 1.000000e-55 |
| GCST011379_7 | Cutaneous mastocytosis (childhood) | 9.000000e-18 |
| GCST011380_3 | Cutaneous mastocytosis (adult) | 1.000000e-09 |
| GCST011381_6 | Cutaneous mastocytosis | 2.000000e-25 |
| GCST011382_4 | Systemic mastocytosis | 7.000000e-12 |
| GCST011383_19 | Mastocytosis | 8.000000e-35 |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
9 total (human), top 9 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| sodium arsenite | increases expression | 1 |
| CGP 52608 | affects binding, increases reaction | 1 |
| perfluoro-n-nonanoic acid | increases expression | 1 |
| perfluorohexanesulfonic acid | increases expression | 1 |
| Grape Seed Proanthocyanidins | affects cotreatment, decreases expression | 1 |
| Resveratrol | affects cotreatment, decreases expression | 1 |
| Benzo(a)pyrene | affects methylation, increases methylation | 1 |
| Catechin | affects cotreatment, decreases expression | 1 |
| Plant Extracts | affects cotreatment, decreases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
- Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): cutaneous mastocytosis, mastocytosis, systemic mastocytosis